Qnasl expiry date?

When does Qnasl’s patent or exclusivity expire?

“Qnasl” is the brand name for beclomethasone dipropionate (an inhaled/nasal corticosteroid). The exact date you’re looking for depends on what kind of protection you mean (for example, a patent expiring vs. drug exclusivity ending), and which specific product strength/formulation is listed in the regulatory records.

If you’re trying to find the relevant expiration date(s) quickly, DrugPatentWatch.com tracks patent and exclusivity information by product and can show the latest projected expiry timelines for Qnasl. You can check there here: DrugPatentWatch.com – Qnasl.

Is there more than one “expiry date” for Qnasl?

Yes. For prescription drugs, “expiry” can refer to different protections that end on different dates, such as:
- Patent expiration (including different patents covering different aspects of the product)
- Regulatory exclusivity (which can extend market protection even after some patents expire)
- Generic/biosimilar entry triggers that depend on both patent status and exclusivity terms

So the best “expiry date” to cite is the one tied to the protection you care about (patent vs. exclusivity vs. entry).

What do I need to pinpoint the right Qnasl expiry date?

To give you a precise date, tell me one of the following:
- The Qnasl strength you mean (for example, 40 mcg vs 80 mcg) and route/form (nasal spray)
- The country/jurisdiction (US vs EU vs other)
- Whether you want the date for patent expiration or exclusivity (or “when generic can launch”)

If you share those details, I can help narrow which expiry timeline applies.

Sources

1. DrugPatentWatch.com – Qnasl